Thursday, August 16, 2018 10:34:33 AM
The Market has spoken and given a collective YAWN at the
last quarter results. We were told by the CEO they would not be good.
NHS requires product go behind the pharmacy for prescription.
That transition dramatically slowed sales.
Keep an eye on Mundipharma while we wait for FDA Clearance and impending contracts.
Negative people in my life get banished, they have shown me exactly who I do not want to hang around with, and who I don't want to be.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM